News
Topline data were announced from a phase 3 trial evaluating efzofitimod in patients with pulmonary sarcoidosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback